By Alan Mozes HealthDay Reporter (HealthDay) MONDAY, Nov. 15, 2021 (HealthDay Information) — Specified frequently approved antidepressants look to significantly lower the chance of dying amid very seriously sick COVID-19 patients, a substantial new research implies. Selective serotonin reuptake inhibitors (SSRIs) are amongst the most …